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1. Introduction 
Laparoscopy is the gold-standard procedure for the diagnosis of tubo-peritoneal infertility.  
However, transabdominal access in laparoscopy is not without major risks, including 
gastrointestinal injuries 1 and major vascular injuries. 2  In 1998, to minimize the 
invasiveness of laparoscopy for diagnostic purposes, transvaginal hydrolaparoscopy (THL) 
was introduced as the first line procedure in the exploration of the adnexal structures in 
infertile women. 3,4  Demonstration of the advantages of THL, such as the ability to 
accurately inspect adnexal structures without manipulation, has made it clear that THL is a 
less traumatic and more suitable outpatient procedure than transabdominal laparoscopy.  
THL can be performed under local anesthesia of the posterior vaginal fornix.  A rigid scope 
is inserted transavginally through the pouch of Douglas, saline is injected for distension, 
and a field of vision thereby becomes available.  Unlike minimally invasive endoscopic 
procedures, the natural office surgery is recently called natural office transluminal 
endoscopic surgery (NOTES). 5 
There are some reports that described the usefulness and prognostic value of diagnostic 
THL in infertile women. 6-8  Moreover, operative THL such as ovarian drilling for 
unovulatory women with polycystic ovarian syndrome (PCOS) to induce ovulation has also 
appeared to be as effective as that by the conventional laparoscopy. 5, 9-13  This procedure is 
named transvaginal hydrolaparoscopic ovarian drilling (THLOD).  THL has also been 
expected to be useful for adhesiolysis in some limited lesions. 
The risk of bowel injury and sepsis by transvaginal access with culdoscopy was higher than 
that with laparoscopy in old reports. 14   However, the value of direct access to the posterior 
pelvis at culdoscopy for infertility investigation is well recognized.  Although the new 
technique of THL differs in the use of the dorsal decubitus position for the patient, a small 
diameter endoscope, and saline solution for peritoneal distension, the principle of THL is 
similar to that of culdoscopy in that its access is through the posterior fornix. 
2. Indication and surgical procedure of THL and THLOD 
We have been performing THL for the following five indications: diagnostic THL7,8 for (i) 
tubal obstruction and/or peritubal adhesion are suggested by hysterosalpingography 
(HSG), (ii) serum antibody against C. trachomatis is positive, (iii) diagnosis of early-stage 
endometriosis, (iv) unexplained infertility, and operative THL 10,12-13 for (v) ovarian drilling 
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using Nd:YAG or Holmium laser in infertile women with polycystic ovary syndrome 
(PCOS).   
However, to avoid the major risks of THL, any of the followings are contraindications:  
i) retroflexed uterus, ii) the past history of pelvic surgery, iii) obstruction of the pouch  
of Douglas by the rectum or a prolapsed tumor, and iv) acute pelvic inflammatory 
disease. 
THL and THLOD were performed in the lithotomy position as we described previously. 7-8, 
10, 12-13, 15-18   Briefly, after premedication, a Hys-cath (Sumitomo Bakelite Co. Ltd., Tokyo, 
Japan) was inserted into the uterine cavity for use in chromotubation.  The uterine cervix 
was lifted with a tenaculum placed on the posterior lip.  Under local anesthesia or general 
anesthesia, a Veress needle was introduced 1.5 cm below the cervix and inserted into the 
pelvic cavity (Figure 1a).  Approximately 100 ml of normal saline solution is instilled 
through the cannula in the pouch of Douglas (Figure 1b, 1c).  For THL, a 3-mm blunt trocar 
was inserted by a stab incision in the posterior fornix and a 2.7-mm diameter semirigid 
endoscope was used at an optical angle of 30° with a flow channel attached to a 3-CCD 
digital videocamera (Figure 1d).  For THLOD, a 5.5-mm blunt trocar is inserted by a stab 
incision in the posterior fornix.  Then a 5.0-mm diameter semirigid endoscope was used 
with the same technique.  The saline irrigation was continued throughout the procedure to 
keep the bowel and tubo-ovarian structures afloat.  The posterior region of the uterus and 
the bilateral tubo-ovarian structures were carefully observed, and tubal passage was 
confirmed using indigocarmine.  In a few cases, the structure could not be observed due to 
severe adhesion.7 
 
a. Insertion of a Veress needle b. Insertion of cannula 
d. Insertion of a laparoscope  
c. Pouring normal saline solution 
e. Introduction of the laser probe 
through the auxiliary channel of the 
sheath  
f. Ovarian drilling with a laser 
 
Fig. 1. Procedure for THL and THLOD 
The procedure for THL and THLOD are described. a) A Veress needle is inserted into the 
pelvic cavity.  b, c) Normal saline solution is instilled through the cannula in the pouch of 
Douglas.  d) A blunt trocar is inserted by a stab incision in the posterior fornix.  Then a 
semirigid endoscope is used with an optical angle of 30° and a flow channel attached to a 3-
CCD digital videocatmera.  Tubal passage is confirmed using indigo carmine.  e, f) THLOD 
is performed using a laser to ablate portions of the ovarian cortex.   
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For THLOD, after careful observation as for diagnostic THL (Figure 2a), ovarian drilling 
was performed using an Nd:YAG laser (STAGE MY-100, LASER PERIPHERALS LLC, MN, 
USA) or Holmium laser (VersaPulse, Boston Scientific, MA, USA) to ablate portions of the 
ovarian cortex (Figure 1e, 1f).  A sterile quartz glass fiber measuring 1 mm in core diameter 
was passed through the operating channel of the laparoscope using a special laser fiber 
steering device with a deflectable tip (Figure 2b, 2c).  The power used ranges up to 10 W.  
The focused laser beam is used at a distance of 1.5 mm to 3.0 mm to create approximately 40 
holes on the surface of each ovary (Figure 2d, 2e, 2f). 
 
a b c 





Fig. 2. Performance of THLOD using a laser  a)A polycystic ovary behind the uterus is 
visible through THL.  b) Introduction of the laser probe through the auxiliary channel of the 
sheath. The focused laser beam was used from a distance of 1.5 mm to 3.0 mm.  c-e) 
Approximately 40 holes were made on the ovarian cortex.  f) Final phase of ovarian drilling. 
3. Visualization of tubo-ovarian structures and salpingoscopy 
Assessment of the Fallopian tube represents an integral part for the evaluation of the infertile 
couple.  Because the findings obtained at hysterosalpingography, laparoscopy, or laparotomy 
are indirect, salpingoscopy has been introduced as an endoscopic examination that can 
directly evaluate the ampullary tubal mucosa.  The standard procedure is transfimbrial 
salpingoscopy performed at the time of laparoscopy.19  It is a microendoscopic approach for 
directly visualizing the tubal mucosa from the ampullary-isthmic junction to the fimbria.  
Clinical and morphological studies have shown a high correlation between the appearance of 
the tubal mucosa and the ultimate outcome in terms of pregnancies.19  Recently, it was 
suggested that performing salpingoscopy with laparoscopy could significantly increase 
accuracy in predicting short-term fertility outcome. 20   However, such salpingoscopy under 
trans-abdominal laparoscopy requires hospitalization and general anesthesia. 
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In some women, endoluminal examination by salpingoscopy can be simultaneously 
performed under THL.  The transvaginal salpingoscopy under THL is less invasive to 
infertile women because it does not require hospitalization or general anesthesia.  The 
procedure was first described by Gordts et al.21  They reported that the fimbriae were 
visualized in all patients with no obvious pelvic pathology, and cannulation of the distal 
tubal segment was achieved without manipulation of the tube in 20% before ovulation and 
55% in the early luteal phase.  Afterward Watrelot et al. 22 reported that salpingoscopies 
were possible in 19% of women with post-PID lesions without the need to stabilize the 
tubes.  However, salpingoscopies were possible in 41% of those women using a grasp 
forceps introduced in the operative channel. 
 
a b c 
d e f 
 
Fig. 3. Visualization of tubo-ovarian structures and salpingoscopy 
a)The posterior of the uterus and the bilateral tubo-ovarian structures were carefully 
observed by THL.  The ovary and fimbria are clearly visible.  b) Tubal passage was 
confirmed using indigocarmine.  A Hys-cath was inserted into the uterine cavity for the use 
of chromotubation.  c) The endoscope was inserted into the ampulla by the guidance of 
chromotubation.  d) The normal looking tubal mucosa under transvaginal salpingoscopy. 
e) Unsuccessful salpingoscopy in a case of extensive peritubal adhesion by past C. 
trachomatis infection.  f) Endosalpingial edema caused by C. trachomatis infection. 
We have also been performing salpingoscopy under THL.  Consecutive series of 130 infertile 
women diagnosed tubo-ovarian structures and tubal passage using THL were 
retrospectively analyzed between May 1999 and November 2003. 17  Access to the pouch of 
Douglas was achieved in 123 (94.6%) of 130 patients.  Twenty-six tubes could not be 
visualized because of extensive adhesion.  Two patients with a history of unilateral 
salpingectomy and a patient with unicorn uterus were excluded.  Therefore, 217 adnexa 
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were clinically evaluated.  The posterior of the uterus and the bilateral tubo-ovarian 
structures were carefully observed (Figure 3a), and tubal passage was confirmed using 
indigocarmine (Figure 3b).  
In 89 (41.0%) of 217 tubes, a salpingoscopy could be performed.  The endoscope was 
inserted from the fimbria by the guidance of chromotubation (Figure 3c) and the distal part 
of the tubal mucosa could be observed (Figure 3d).  To increase the success of salpingoscopy 
rates, it may be necessary to stabilize the tubes using grasp forceps to introduce an operative 
channel demonstrated by Watrelot et al.22   
However, a past history of C. trachomatis infection did not seem to influence the success of a 
salpingoscopy because extensive peritubal adhesion by past C. trachomatis infection may 
disturb visualizing the tubes themselves (Figure 3e).  Therefore, we speculate that the 
successful salpingoscopy rate was similar between women with and without past C. 
trachomatis infection.  Typical tubal damages by C. trachomatis infection include verruca and 
atypical vessel formation, peritubal adhesion, and endosalpingial edema (Figure 3f). 
4. Transvaginal Hydrolaparoscopic Ovarian Drilling (THLOD) 
Polycystic ovary syndrome (PCOS) is a syndrome of ovarian dysfunction showing 
cardinal features of hyperandrogenism and polycystic ovarian morphology.23  It is one of 
the most common reproductive endocrine disorders in young adult women, showing 
clinical signs of menstrual disorder, anovulation, hirsutism, acne, and obesity.  
Frequently, this group of patients present with infertility due to chronic oligoovulation or 
anovulation.  Approximately 15 % of patients with PCOS remain anovulatory despite 
treatment with clomiphene citrate, and half of patients with PCOS who become ovulatory 
on this treatment fail to conceive.24  The alternative of gonadotropin stimulation or 
surgical treatment is often the next step for the treatment of clomiphene citrate-resistant 
infertile women with PCOS. 
Since Stein and Leventhal reported that all women menstruated regularly post ovarian 
wedge resection and some of them conceived, 25 ovarian surgery has been used to induce 
ovulation following unsuccessful medical induction of ovulation.  Ovarian surgery has 
also been indicated in women who hyper-respond to gonadotropin therapy in order to 
avoid such complications as ovarian hyperstimulation syndrome (OHSS) or multiple 
gestations. 
In recent years, however, because of the rapidly expanding use of techniques involving 
laparoscopy, surgical treatment has received renewed interest.  Laparoscopic ovarian 
drilling (LOD) by the trans-abdominal approach has been widely used to induce ovulation 
in women with PCOS after failure of treatment with clomiphene citrate. 26  So far, it has been 
shown that LOD is effective for inducing ovulation, and the pregnancy rate following LOD 
seems to be acceptable. 
Near the end of the 20th century, THL was developed and it was offered for the operative 
laparoscopy, especially in women with PCOS for ovarian drilling.  This novel technique, 
THLOD using a laser or bipolar electrosurgery, appears to be an effective minimally 
invasive procedure to induce ovulation in women with PCOS.5, 9-13  Fernandez et al.9.11 have 
recently reported the feasibility of ovarian drilling by THL for PCOS.  They reported the 
usefulness of THL for the treatment of PCOS by ovarian drilling.  They performed ovarian 
drilling using bipolar electrosurgery by THL in 80 clomiphene citrate-resistant anovulatory 
women with PCOS.  During a mean follow-up of 18.1 months, 73 (91 %) patients recovered 
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regular ovulatory cycles.  The cumulative pregnancy rate was 60 % for spontaneous and 
stimulated cycles, with 40% imputed to drilling alone. 11  It was suggested that THLOD has 
the same effectiveness as trans-abdominal LOD.  It was also reported that there were no 
complications. 
Our group has also been performing THLOD using a laser.10, 12-13  THLOD has 3 advantages 
when it was compared with gonadotropin treatments for ovulation induction.  Ovulation 
and pregnancy rates are the same as those for gonadotropin treatments.  OHSS and multiple 
pregnancies are reduced.  Furthermore, if ovulation is achieved, the frequency of visiting the 
outpatient clinic for monitoring the follicular status can be reduced.  However, THLOD 
might have some disadvantages, including the risks of anesthetic and operative 
complications or possible recurrence of oligoovulatory cycles. 
So far, 7 infertile women with PCOS, including 5 women with clomiphene citrate-resistant 
PCOS and 2 women with the risk of developing OHSS, have undergone THLOD.  Except for 
one patient who dropped out of the study, 6 patients resumed having regular ovulatory 
cycles without developing OHSS.  In 4 (67%) of 6 patients, pregnancies were established; 
one by timed intercourse during the spontaneous cycle, two by intra-uterine insemination 
following clomiphene-FSH-HCG treatment, and one by IVF-ET.  The pregnancy courses in 
these patients have been uneventful to this point.  There were no intra- or postoperative 
complications of THLOD.12   
5. Complications 
The risk and outcome of bowel injury during THL were previously reported by Gordts et 
al.27  They carried out a multinational retrospective survey based on confidential, self-
reported cases from 39 gynecologists in 18 different countries.  In their 3667 procedures, a 
total of 24 bowel injuries were experienced, giving an incidence of 0.65 %.   
In our experience, two cases of bowel injury were diagnosed during 168 diagnostic THL 
procedures.  In both cases, the injuries were extraperitoneal and were treated conservatively 
with antibiotics without major consequences.  No complication occurred during THLOD in 
9 patients with PCOS.  In total, 2 (1.1 %) of 177 cases were diagnosed with bowel injury. 28  
In addition to the report by Gordts et al.,14 we reported our experiences with a review of 
another series of 549 patients from 9 reported studies published after the year of 2000. 28  
Only our study reported bowel injury associated with diagnostic THL.  Two (0.35 %) of 565 
patients from the 9 studies published after the report of Gordts et al. 27 suffered bowel 
injury.  There is no significant difference of the incidence (0.65 %) of bowel injuries reported 
by Gordts et al. 27 and that (0.35 %) in the other 9 reports (P = 0.39).  They also reported that 
the site of injury involved the extraperitoneal rectum in 21 patients and the rectosigmoid in 
3 cases.  No leakage of bowel content was reported in their report.  Twenty-two (92 %) of the 
cases were managed expectantly without consequences.  These low incidences of major 
complications should be encouraging for clinicians who have already performed THL as 
well as those who are now considering introducing THL in their clinics. 
As for perforation of the retroflexed uterus, only one case report was obtained.29  The incidence 
of perforation of the retroflexed uterus was 0.02 %.  In this era of wide use of transvaginal 
ultrasonography, it is likely that such a complication will seldom occur if clinicians carefully 
perform transvaginal ultrasonography before judging whether THL is indicated. 
To avoid possible bowel injury during THL in patients with appropriate indication and 
without contraindication, prophylactic use of a laxative and/or enema before the procedure 
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should be considered.  Theoretically, it seems that it would be easier to access the pouch of 
Douglas with less risk if the rectum were not full of stools.  Moreover, clinicians should take 
care when they introduce or re-introduce the Veress needle toward the left pelvic cavity for 
the anatomical reasons. 
6. Conclusion 
The usefulness of THL for diagnostic and operative purposes is in no doubt. Moreover, 
endoluminal assessment by transvaginal salpingoscopy can be simultaneously performed in 
some infertile women, especially with patent tubes or with regular tubes undergoing THL. 
Ovarian surgery for the treatment of PCOS has been shown to be useful in anovulatory 
infertile women who do not respond to medical induction of ovulation.  LOD by the trans-
abdominal approach has been used to induce ovulation in women with PCOS after failure of 
treatment with clomiphene citrate.  Following the introduction of THL as the first line 
procedure for the diagnostic laparoscopy, THLOD was developed as an alternative 
minimally invasive surgery for PCOS patients.   
However, informed consent and careful procedure before and during THL/THLOD should 
be carried out although they can be done on an outpatient clinic basis.   
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